What are the top competitors of CASI Pharmaceuticals, Inc. in Healthcare sector?

The top competitors of CASI Pharmaceuticals, Inc. in the Healthcare sector are: Iterum Therapeutics plc (ITRMF), Ocean Biomedical, Inc. (OCEA), Affimed N.V. (AFMDQ), Biora Therapeutics, Inc. (BIORQ).

Which has better valuations & earnings, CASI Pharmaceuticals, Inc. or its competitors?

CASI Pharmaceuticals, Inc. has a market cap of 4.1M and a Dividend Yield of N/A compared to its competitors.

Which stock is more profitable: CASI Pharmaceuticals, Inc. or its competitors?

CASI Pharmaceuticals, Inc. has an EPS of $-2.59, while ITRMF has an EPS of $-0.72. So, CASI Pharmaceuticals, Inc. is more profitable compared to ITRMF.

What is CASI Pharmaceuticals, Inc. stock volatility and risk in terms of investment?

CASI Pharmaceuticals, Inc. has daily volatility of 33.33% as compared to its competitor ITRMF which is 24.72%. CASI Pharmaceuticals, Inc. is more volatile as compared to competitors and has high risk.

Is CASI Pharmaceuticals, Inc. stock profitable?

CASI Pharmaceuticals, Inc. has a Return on Equity (ROE) of 3.58%. So, CASI Pharmaceuticals, Inc. is more profitable.

What is CASI Pharmaceuticals, Inc. stock’s 52 weeks high and low?

CASI Pharmaceuticals, Inc. stock has a 52-week high of ($3.09) and a low of ($0.05).

What was the average volume of CASI Pharmaceuticals, Inc. stock?

The average volume of CASI Pharmaceuticals, Inc. is (12.4K) in terms of investment.

CASI Pharmaceuticals, Inc. (CASIF) Stock Competitors & Peer Comparison

See (CASIF) competitors and their performances in Stock Market.

CASIF●PNK

HealthcareBiotechnology

$0.20

$0.06(42.86%)

U.S. Market opens in 16h 4m

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

Symbol	Price	Change %	Market Cap	P/E Ratio	EPS	Dividend Yield
CASIF	$0.20	+42.86%	4.1M	-0.08	-$2.59	N/A
ITRMF	$0.04	-12.25%	1.9M	-0.05	-$0.72	N/A
OCEA	$0.00	-33.33%	118.6K	N/A	-$0.91	N/A
AFMDQ	$0.00	+0.00%	1.6K	N/A	-$5.24	N/A
BIORQ	$0.00	+0.00%	452	N/A	N/A	N/A

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

CASIF vs ITRMF Comparison June 2026

CASIF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CASIF stands at 4.1M. In comparison, ITRMF has a market cap of 1.9M. Regarding current trading prices, CASIF is priced at $0.20, while ITRMF trades at $0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CASIF currently has a P/E ratio of -0.08, whereas ITRMF's P/E ratio is -0.05. In terms of profitability, CASIF's ROE is +3.58%, compared to ITRMF's ROE of +6.02%. Regarding short-term risk, CASIF is more volatile compared to ITRMF. This indicates potentially higher risk in terms of short-term price fluctuations for CASIF.Check ITRMF's competition here